Skip to main content
. Author manuscript; available in PMC: 2023 Jun 26.
Published in final edited form as: Mol Pharm. 2020 Sep 16;18(2):714–725. doi: 10.1021/acs.molpharmaceut.0c00461

Table 1.

Characterization of pApoE2 Entrapped Liposomesa

formulation particle size (nm) zeta potential (mV) PDI entrapment efficiency (%)
plain liposomes 178.6 ± 0.90 16.4 ± 0.5 0.302 ± 0.18 86.78 ± 1.62
MAN liposomes 160.9 ± 7.44* 14.9 ± 5.8 0.238 ± 0.12 83.79 ± 4.44
Pen liposomes 171.5 ± 4.91# 19.9 ± 1.3 0.230 ± 0.09 88.40 ± 6.20
PenMAN liposomes 172.0 ± 3.09#^ 19.0 ± 0.9 0.191 ± 0.04 86.30 ± 1.55
RVG liposomes 154.6 ± 3.96*+ 18.5 ± 0.1 0.249 ± 0.01 85.50 ± 2.25
RVGMAN liposomes 167.8 ± 2.47*^ 19.8 ± 3.6 0.132 ± 0.10 84.50 ± 5.90
a

Data represent mean ± SD of four replicates.

*, #, +, and ^ indicate statistically (p < 0.05) different from plain, MAN, Pen, and RVG liposomes, respectively.